SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-017109
Filing Date
2021-01-26
Accepted
2021-01-26 08:46:54
Documents
15
Period of Report
2021-01-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d118113d8k.htm   iXBRL 8-K 42416
2 EX-3.1 d118113dex31.htm EX-3.1 15669
3 EX-3.2 d118113dex32.htm EX-3.2 82975
4 EX-10.1 d118113dex101.htm EX-10.1 64507
  Complete submission text file 0001193125-21-017109.txt   381283

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA eidx-20210125.xsd EX-101.SCH 3054
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE eidx-20210125_lab.xml EX-101.LAB 19638
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eidx-20210125_pre.xml EX-101.PRE 12301
8 EXTRACTED XBRL INSTANCE DOCUMENT d118113d8k_htm.xml XML 3662
Mailing Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104
Business Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104 650-391-9740
Eidos Therapeutics, Inc. (Filer) CIK: 0001731831 (see all company filings)

IRS No.: 463733671 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38533 | Film No.: 21551807
SIC: 2834 Pharmaceutical Preparations